Vistagen Therapeutics Inc (VTGN)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.17-10.36%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · VTGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 2.5 | 1.3 | 0.5 | 1.1 | (0.2) | 1.1 | 1.1 | 0.0 | — | 0.0 | 1.3 | 0.0 |
| Total Revenues | — | — | — | — | (0.2) | 1.1 | 1.1 | 0.0 | — | 0.0 | 1.3 | 0.0 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 54.2 | 55.0 | 39.4 | 20.0 | 44.4 | 35.4 | 11.9 | 13.4 | 17.1 | 7.8 | 5.2 | 3.9 |
| Operating Income | (69.7) | (72.1) | (56.0) | (33.0) | (59.3) | (47.8) | (17.9) | (20.8) | (24.6) | (14.2) | (10.2) | (17.9) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.8 |
| EBT, Incl. Unusual Items | (67.6) | (69.7) | (51.4) | (29.4) | (59.2) | (47.8) | (17.9) | (20.8) | (24.6) | (14.3) | (10.3) | (47.2) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||
| Net Income | (67.6) | (69.7) | (51.4) | (29.4) | (59.2) | (47.8) | (17.9) | (20.8) | (24.6) | (14.3) | (10.3) | (47.2) |
| Per Share | ||||||||||||
| Basic EPS | (1.57) | (1.83) | (1.67) | (1.52) | (8.51) | (0.25) | (0.49) | — | — | — | — | (29.08) |
| Diluted EPS | (1.57) | (1.83) | (1.67) | (1.52) | — | — | — | — | — | — | — | (29.08) |
| Revenue per Share | 0.06 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 43.0 | 38.1 | 30.9 | 19.4 | 7.0 | 198.0 | 86.1 | — | — | — | — | 1.8 |
| Diluted Weighted Avg Shares | 43.0 | 38.1 | 30.9 | 19.4 | — | — | — | — | — | — | — | 1.8 |
| Supplemental | ||||||||||||
| EBITDA | — | (71.9) | (55.8) | (32.9) | (59.1) | (47.6) | (17.8) | (20.7) | (24.5) | (14.1) | (10.2) | (17.8) |
| EBIT | (69.7) | (72.1) | (56.0) | (33.0) | (59.3) | (47.8) | (17.9) | (20.8) | (24.6) | (14.2) | (10.2) | (17.9) |
| Effective Tax Rate | — | — | — | — | — | — | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.